Loomis, Sayles & Company’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.9M | Sell |
|
|||||
|
2025
Q1 | $77M | Sell |
|
|||||
|
2024
Q4 | $81.1M | Sell |
|
|||||
|
2024
Q3 | $88.3M | Sell |
|
|||||
|
2024
Q2 | $82.2M | Sell |
|
|||||
|
2024
Q1 | $40.5M | Sell |
|
|||||
|
2023
Q4 | $72.3M | Sell |
|
|||||
|
2023
Q3 | $60.2M | Buy |
|
|||||
|
2023
Q2 | $34M | Sell |
|
|||||
|
2023
Q1 | $27.8M | Buy |
|
|||||
|
2022
Q4 | $24.5M | Sell |
|
|||||
|
2022
Q3 | $27.1M | Sell |
|
|||||
|
2022
Q2 | $25.1M | Sell |
|
|||||
|
2022
Q1 | $30M | Sell |
|
|||||
|
2021
Q4 | $35.5M | Buy |
|
|||||
|
2021
Q3 | $34M | Buy |
|
|||||
|
2021
Q2 | $22.1M | Sell |
|
|||||
|
2021
Q1 | $26.9M | Sell |
|
|||||
|
2020
Q4 | $26.4M | Buy |
|